Generic name: NALDEMEDINE TOSYLATE .2mg
Dosage form: tablet
Medically reviewed on January 1, 2018.
- Alteration of analgesic dosing regimen prior to initiating SYMPROIC is not required.
- Patients receiving opioids for less than 4 weeks may be less responsive to SYMPROIC [see Clinical Studies (14)].
- Discontinue SYMPROIC if treatment with the opioid pain medication is also discontinued.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
More about Symproic (naldemedine)
- Symproic Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 6 Reviews
- Drug class: peripheral opioid receptor antagonists